spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ADVENTRX Pharmaceuticals 

 HSMN NewsFeed - 28 Feb 2013
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2012
ADVENTRX Announces Appointment Of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2011
ADVENTRX Announces Appointment of Senior Vice President, Commercial
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2011
ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Jun 2010
ADVENTRX Grants Exclusive Worldwide Rights to CoFactor Know-How and Data
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Mar 2010
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2010
ADVENTRX Announces Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2009
Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2008
ADVENTRX Exploring Strategic Options
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2008
ADVENTRX Settles Dispute With Former Licensee
Biopharmaceuticals Licensing Litigation
 HSMN NewsFeed - 9 Apr 2008
ADVENTRX Appoints Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2008
ADVENTRX Announces Consolidation of Clinical and Management Positions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2007
ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Nov 2007
ADVENTRX Provides Update on Cofactor(R) Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Oct 2007
ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Aug 2007
ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Jun 2007
Jack Lief Named Chairman of ADVENTRX Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2007
ADVENTRX and TRx Pharma Announce Zanaflu(R) Registered as the Brand Name for ANX-211 (Chitosan Gel)
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2007
ADVENTRX Appoints Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Dec 2006
ADVENTRX Initiates CoFactor Phase II Clinical Trial in Refractory Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Dec 2006
ADVENTRX Announces Appointment of Veteran Finance and Biotech Industry Executive Gregory P. Hanson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2006
ADVENTRX Announces Senior Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2006
ADVENTRX Appoints Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Aug 2006
ADVENTRX Announces Appointment of General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2006
ADVENTRX Presents Encouraging New Supplemental Results for the CoFactor Phase II Metastatic Colorectal Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jun 2006
ADVENTRX Presents CoFactor Pharmacokinetics Data
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2006
ADVENTRX Initiates CoFactor Phase III Clinical Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jun 2006
Data Safety Monitoring Board Recommends Continuation of ADVENTRX Phase IIb Clinical Trial for CoFactor
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jun 2006
ADVENTRX Announces Positive CoFactor Phase II Clinical Trial Results at ASCO Conference
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2006
ADVENTRX Receives FDA Clearance Under a Special Protocol Assessment to Initiate CoFactor Phase III Clinical Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2006
ADVENTRX Announces Closing of Merger With SD Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 20

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 20 additional stories matching:
ADVENTRX Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.